Bandingkan Harga & Kinerja Gudang Garam Tbk. (GGRM) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Gudang Garam Tbk. dan Organon Pharma Indonesia Tbk.: Gudang Garam Tbk. diperdagangkan di Rp19.375 (kapitalisasi pasar 37,52 T, volume 24 jam 424,7 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Gudang Garam Tbk. jauh lebih besar — sekitar 359,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GGRM | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 37,52 T | 104,4 M |
Volume | 424,7 rb | — |
Lot | 4,25 rb | — |
Perputaran | 8,22 M | — |
Harga Rata-rata | 19.361,49 | — |
Nilai Transaksi | 8,22 M | — |
Harga Ekuilibrium Indikatif | 19.375 | — |
Volume Ekuilibrium Indikatif | 168 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Gudang Garam Tbk.
PT Gudang Garam Tbk (the Company), previously named as PT Perusahaan Rokok Tjap Gudang Garam Kediri was established by Deed of Mr. Suroso S.H., acting notary public in Kediri, dated 30 June 1971 No. 10 amended by deed of the same notary dated 13 October 1971 No. 13. The Company is a continuation of a Proprietorship which was established in 1958. In 1969, the Company changed its legal status to a Partnership and in 1971 it was further changed its legal entity as a Limited Liability Company. Commercial operation was commenced in 1958.
Selengkapnya di halaman GGRM →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
